Shares of Waldencast plc (NASDAQ:WALD – Get Rating) traded up 2.5% during trading on Wednesday . The company traded as high as $9.99 and last traded at $9.30. 6,308 shares traded hands during trading, an increase of 202% from the average session volume of 2,091 shares. The stock had previously closed at $9.08.
Analyst Upgrades and Downgrades
Separately, DA Davidson upped their target price on shares of Waldencast from $12.00 to $15.50 and gave the stock a "buy" rating in a research note on Thursday, November 17th.
Get
Waldencast alerts:
Waldencast Stock Up 2.5 %
The company's 50 day moving average price is $9.37 and its 200-day moving average price is $9.13.
Institutional Trading of Waldencast
Institutional investors have recently made changes to their positions in the company. Truxt Investmentos Ltda. purchased a new position in shares of Waldencast in the 3rd quarter worth about $50,000,000. Sculptor Capital LP boosted its holdings in shares of Waldencast by 160.8% in the 2nd quarter. Sculptor Capital LP now owns 3,092,804 shares of the company's stock worth $30,464,000 after buying an additional 1,906,998 shares during the last quarter. Citadel Advisors LLC boosted its holdings in shares of Waldencast by 4.2% in the 2nd quarter. Citadel Advisors LLC now owns 1,821,698 shares of the company's stock worth $17,943,000 after buying an additional 72,975 shares during the last quarter. RPO LLC boosted its holdings in shares of Waldencast by 865.6% in the 2nd quarter. RPO LLC now owns 619,443 shares of the company's stock worth $6,101,000 after buying an additional 555,292 shares during the last quarter. Finally, JPMorgan Chase & Co. purchased a new position in shares of Waldencast in the 2nd quarter worth about $5,597,000. Institutional investors own 18.80% of the company's stock.
About Waldencast
(Get Rating)
Waldencast plc, a skincare company, develops, markets, and sells skin health products worldwide. The company offers approximately 200 cosmetic, over-the-counter, and prescription products under the Obagi Medical, Obagi Clinical, and Obagi Professional brands; and a Skintrinsiq device for use in facial treatments that is used by physicians' offices, spas, and aestheticians.
Further Reading
- Get a free copy of the StockNews.com research report on Waldencast (WALD)
- 3 Health Care Stocks Paying Reliable Dividends
- Will Canada Goose Stock Fly Higher for the Winter?
- Buffett's Next Bet Is One Of His Biggest Ever
- Apple Stock Pulls Back, Is Now the Time To Buy?
- Is A Short-Squeeze In Mullen Automotive About To Begin?
Receive News & Ratings for Waldencast Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Waldencast and related companies with MarketBeat.com's FREE daily email newsletter.
